The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test

被引:5
|
作者
Berthelsen, Mona [1 ]
Berstad, Paula [1 ,7 ]
Randel, Kristin R. [1 ]
Hoff, Geir [1 ,2 ,3 ]
Natvig, Erik [1 ]
Holme, Oyvind [4 ,5 ]
Botteri, Edoardo [1 ,6 ]
机构
[1] Canc Registry Norway, Sect Colorectal Canc Screening, POB 5313 Majorstuen, N-0304 Oslo, Norway
[2] Telemark Hosp Trust, Dept Res & Dev, Ulefossvegen 55, N-3710 Skien, Norway
[3] Univ Oslo, Inst Clin Med, POB 1171 Blindern, N-0318 Oslo, Norway
[4] Sorlandet Hosp, Dept Med, POB 416 Lundsiden, N-4604 Kristiansand, Norway
[5] Univ Oslo, Inst Hlth & Soc, POB 1130 Blindern, N-1130 Oslo, Norway
[6] Canc Registry Norway, Dept Res, POB 5313 Majorstuen, N-0304 Oslo, Norway
[7] Canc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway
关键词
Colorectal cancer screening; Driving time; Faecal immunochemical test; Participation; Sigmoidoscopy; BREAST-CANCER; DISPARITIES; POPULATION; PREDICTORS; BARRIERS;
D O I
10.1016/j.canep.2022.102244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High participation rates are important for a colorectal cancer (CRC) screening programme to be effective. Having a long travelling distance to screening centres may impede participation.Methods: We analysed the association between driving time from home address to screening centre and participation among individuals invited to screening with faecal immunochemical test (FIT) (n = 68,624) or sigmoidoscopy (n = 46,076) in a randomized trial in Norway in 2012-17. Two screening centres were involved. We fitted multiple logistic regression models, adjusted for demographic, socioeconomic and health characteristics, and reported odds ratios (OR) with 95% confidence intervals (CI). Results: Participation rates were 58.9 % (n = 40,445) for FIT and 51.9 % (n = 23,911) for sigmoidoscopy. In sigmoidoscopy, participation was 56.9 % and 47.9 % in those living < 20 and > 60 min by car from the screening centres, respectively. For each 10 min driving time increase, OR for participating in sigmoidoscopy screening was 0.93 (95 % CI 0.91-0.95). There was a significant difference between the two screening centres (p-value for heterogeneity <0.001). Participation in FIT screening were 61.2 % and 57.1 % in those with < 20 and > 60 min driving time, respectively, and the OR was 0.98 (95 % CI 0.96-0.99) for each 10 min increase (heterogeneity between screening methods, P-value <0.001). Among those with a positive FIT, compliance to colonoscopy was higher in those living < 20 compared to > 60 min from the centres (95.1 % vs. 92.9 %, respectively, OR 0.86; 95 % CI 0.77-0.93 for each 10 min increase).Conclusions: Driving time to screening centre was a significant predictor of participation, mainly in sigmoidoscopy. There were local differences in the impact of driving time on participation. Driving time also affected compliance to colonoscopy after a positive FIT. When planning a CRC screening programme, one should consider offering people living far from screening sites special assistance to facilitate their participation.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy
    Hol, L.
    van Leerdam, M. E.
    van Ballegooijen, M.
    van Vuuren, A. J.
    van Dekken, H.
    Reijerink, J. C. I. Y.
    van der Togt, A. C. M.
    Habbema, J. D. F.
    Kuipers, E. J.
    GUT, 2010, 59 (01) : 62 - 68
  • [32] Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme
    Hol, Lieke
    Kuipers, Ernst J.
    van Ballegooijen, Marjolein
    van Vuuren, Anneke J.
    Reijerink, Jaqueline C. I. Y.
    Habbema, Dik J. F.
    van Leerdam, Monique E.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) : 2096 - 2102
  • [33] Faecal occult blood test screening for colorectal cancer
    Bolin, TD
    Korman, MG
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (06): : 836 - 836
  • [34] Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test
    Portillo, Isabel
    Arana-Arri, Eunate
    Gutierrez-Ibarluzea, Inaki
    Bilbao, Isabel
    Luis Hurtado, Jose
    Sarasqueta, Cristina
    Idigoras, Isabel
    Bujanda, Luis
    Hurtado, Jose Luis
    de No, Carmen
    Enciso, Carlos
    Escalante, Maite
    Francisco Erana, Luis
    Atares, Begona
    Javier Aguirre, Jose
    Pereda, Esther
    Maranon, Edurne
    Otazua, Pedro
    Fernandez, Maria
    Francisco Egido, Jose
    Zapata, Eva
    Zubiaurre, Leire
    Mari Rodriguez, Juana
    Esteban Sampedro, Pedro
    Goyeneche, Marisa
    Maria Arrinda, Jose
    Milagros Gomez, Mari Carmen
    Luz Jauregui, Mari
    Gomez, Marta
    Saiz, Marta
    Rotaeche, Rafael
    Gutierrez-Stampa, Maria A.
    Aguilar-Gama, Vanessa
    Bujanda, Luis
    Gil, Ines
    Banales, Jesus
    Perugorria, Maria J.
    D'Amato, Mauro
    Sarasqueta, Cristina
    Herreros-Villanueva, Marta
    Gutierrez-Stampa, Marian
    Aguilar-Gama, Vanessa
    Montalvo, Isabel
    Miguel Larzabal, Jose
    Garmendia, Maddi
    Izquierdo, Fernando
    Javier Fernandez, Francisco
    Rodriguez, Iago
    Huerta, Alain
    de Miguel, Eduardo
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 (06): : 1143 - 1148
  • [35] Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening
    Markus Dines Knudsen
    Paula Berstad
    Anette Hjartåker
    Elisabeth Haagensen Gulichsen
    Geir Hoff
    Thomas de Lange
    Tomm Bernklev
    Edoardo Botteri
    British Journal of Cancer, 2017, 117 : 461 - 469
  • [36] Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening
    Knudsen, Markus Dines
    Berstad, Paula
    Hjartaker, Anette
    Gulichsen, Elisabeth Haagensen
    Hoff, Geir
    de Lange, Thomas
    Bernklev, Tomm
    Botteri, Edoardo
    BRITISH JOURNAL OF CANCER, 2017, 117 (04) : 461 - 469
  • [37] Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community
    Hughes, K
    Leggett, B
    Del Mar, C
    Croese, J
    Fairley, S
    Masson, J
    Aitken, J
    Clavarino, A
    Janda, M
    Stanton, WR
    Tong, SL
    Newman, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2005, 29 (04) : 358 - 364
  • [38] Association between lifestyle and site-specific advanced colorectal lesions in screening with faecal immunochemical test and sigmoidoscopy
    Knudsen, Markus D.
    Botteri, Edoardo
    Holme, Oyvind
    Hjartaker, Anette
    Song, Mingyang
    Thiis-Evensen, Espen
    Norvard, Espen R.
    Schult, Anna L.
    Randel, Kristin R.
    Hoff, Geir
    Berstad, Paula
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (03) : 353 - 359
  • [39] The impact of immunochemical faecal occult blood testing on colorectal cancer incidence
    Ventura, Leonardo
    Mantellini, Paola
    Grazzini, Grazia
    Castiglione, Guido
    Buzzoni, Carlotta
    Rubeca, Tiziana
    Sacchettini, Claudio
    Paci, Eugenio
    Zappa, Marco
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (01) : 82 - 86
  • [40] Perceived barriers and benefits in the participation in faecal occult blood test colorectal cancer screening programme
    Rodriguez, Martin Menendez
    Garcia-Morales, Natalia
    Pillado, Teresa Seoane
    Ramirez, Jorge Garau
    Salvador, Alba Traver
    Jimenezf, Yesica Hervas
    Vieito, Noel Pin
    Rodriguez, Luis Menendez
    Cubiella, Joaquin
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (03): : 185 - 194